🧬Microbiome Therapeutics
Therapeutics targeting the gut microbiome and its role in disease — live biotherapeutics and microbiome-based diagnostics.
Market Cap$300.4M
1D-1.89%
Companies84
Public Cos4
SECTOR MARKET CAP
$300.4M-96.8%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | France | $145.4M | MAAT.PA |
| 2 |  | Sweden | $77.4M | IBT-B.ST |
| 3 |  | United States | $73.8M | MCRB |
| 4 |  | United States | $3.9M | AZTR |